Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

By K. Kuck, R. Cappato, J. Siebels, R. Rüppel. Circulation, 2000

1,477 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006, background): “In the Cardiac Arrest Study Hamburg (CASH) study, patients older than 65 y derived a greater benefit from ICD implantation than younger patients.(643) It is therefore appropriate to infer that the results of these trials are applicable to elderly patients across the board.”
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. (2002, background): “Symptomatic NSVT + EPS positive 23 (9) 13 (5) .”
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. (2008, background): “Trials of the ICD in patients who have been resuscitated from cardiac arrest demonstrate survival benefits with ICD therapy compared with electrophysiologically guided drug therapy with Class I agents, sotalol, and empirical amiodarone therapy (320,323).”